Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERATE: Tibolone for Climacteric Symptoms in Breast Cancer Survivors
NCT00408863Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2002
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of tibolone in menopause, sponsored by Organon & Co.. Started May 2002; status: completed.
02
Drugs
tibolone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00408863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408863.